Vanda Pharmaceuticals adds former U.S. Surgeon General, Steven Galson, to its Board of Directors ROCKVILLE, MD

Vanda Pharmaceuticals adds former U.S. Surgeon General,

Steven Galson, to its Board of Directors

ROCKVILLE, MD July 1, 2010 Vanda Pharmaceuticals Inc. (Nasdaq: VNDA), announced today that Dr.

Steven Galson, former Acting U.S. Surgeon General, has joined Vanda s Board of Directors.

I would like to personally welcome Dr. Galson to our Board, said Mihael H. Polymeropoulos, M.D.,

President and Chief Executive Officer of Vanda. We are very fortunate to have a public health

physician on our Board as we continue to develop and commercialize important treatments. Dr.

Galson s experience as the former Acting U.S. Surgeon General and Deputy Director and Director of

the Center for Drug Evaluation and Research will add tremendous value to the Board, Dr.

Polymeropoulos added.

Currently, Dr. Galson is the Senior Vice President for the Civilian Health Operation at Science

Applications International Corporation (SAIC). He has also held executive positions in the U.S.

Environmental Protection Agency, U.S. Department of Energy, and the Centers for Disease Control and

Prevention s National Institute for Occupational Safety and Health. Dr. Galson graduated from the

State University of New York at Stony Brook where he earned a Bachelor of Science degree in

biochemistry. He later earned a Doctor of Medicine degree from the Mt. Sinai School of Medicine,

and a Master of Public Health degree from the Harvard School of Public Health. A retired rear

admiral from the U.S. Public Health Service Commissioned Corps, Dr. Galson is also board certified

in general preventive medicine, public health, and occupational medicine.

About Vanda Pharmaceuticals Inc:

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and

commercialization of clinical-stage products for central nervous system disorders. For more on

Vanda, please visit http://www.vandapharma.com.

Media/Investor Inquiries